John MENDLEIN

City:

Encinitas, California

Country:

United States

Published Applications:

Last publication date:

2020-10-29

Top Assignees for applications by John MENDLEIN

The entities that hold a legal rights for patent applications filed by inventor MENDLEIN John:

BRISTOL-MYERS SQUIBB COMPANY 3 Princeton, NJ United States
FATE THERAPEUTICS, INC. 2 San Diego, CA United States

Recent patent applications by MENDLEIN John

John MENDLEIN from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-10-29

US20200339953A1

Chemistry; metallurgy

HEMATOPOIETIC STEM AND PROGENITOR CELL THERAPY

#2 | 2019-07-04

US20190202894A1

Chemistry; metallurgy

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#3 | 2017-07-06

US20170190761A1

Chemistry; metallurgy

Methods of treating cancer by administering IGF-IR binding molecules

#4 | 2015-09-10

US20150252097A1

Chemistry; metallurgy

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR

#5 | 2014-06-19

US20140171625A1

Chemistry; metallurgy

CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS

#6 | 2014-01-30

US20140030232A1

Chemistry; metallurgy

HEMATOPOIETIC STEM AND PROGENITOR CELL THERAPY

#7 | 2013-11-21

US20130310317A1

Human necessities

TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR

#8 | 2011-12-01

US20110293727A1

Human necessities

CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME

#9 | 2011-12-01

US20110293726A1

Human necessities

CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME

#10 | 2011-12-01

US20110293725A1

Chemistry; metallurgy

CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME

InventorID:

539573 ⎘